scholarly journals Long-Term Follow-up of a Homozygous Familial Hypercholesterolemia Child with Progressive Aortic Stenosis and Coronary Atherosclerosis

2020 ◽  
Author(s):  
Gaojun Cai ◽  
Long Jiang ◽  
Ya Yang ◽  
Liyuan Sun ◽  
Xu Wang ◽  
...  

Abstract Familial hypercholesterolemia (FH) is a severe autosomal-dominant disorder. We reported a case who firstly admitted to our institution for obvious cutaneous and tendinous xanthomas and high low-density lipoprotein cholesterol when he was 3.7 year old in 2005. DNA sequencing detected the homozygous mutation in LDLR exon9 c.1187-10G>A, a 3' splice acceptor mutation in poly-pyrimidine tract of intron 8. During the long-term follow-up, progressive aortic stenosis and coronary atherosclerosis was found, although given the lipid-lowing drugs. HoFH with c.1187-10G>A mutation in LDLR gene might lead to severe damage in cardiovascular system and unsatisfactory response to conventional lipid-lowing drugs. Other aggressive treatments should be used in HoFH patients with this mutation as early as possible.

2008 ◽  
Vol 12 (3) ◽  
pp. 195-201 ◽  
Author(s):  
Jean-Bernard Palcoux ◽  
Marielle Atassi-Dumont ◽  
Patrice Lefevre ◽  
Olivier Hequet ◽  
Jean-Louis Schlienger ◽  
...  

Global Heart ◽  
2018 ◽  
Vol 13 (4) ◽  
pp. 513
Author(s):  
G.A. Cortez Quiroga ◽  
M.C. Durán Torralba ◽  
C. Rus Mansilla ◽  
D. Fatela Cantillo ◽  
A. Fernández Suárez

2019 ◽  
Vol 8 (7) ◽  
pp. 1080 ◽  
Author(s):  
Luís Masana ◽  
Alberto Zamora ◽  
Núria Plana ◽  
Marc Comas-Cufí ◽  
Maria Garcia-Gil ◽  
...  

In the statin era, the incidence of atherosclerotic cardiovascular diseases (ASCVD) in patients with familial hypercholesterolemia (FH) has not been updated. We aimed to determine the incidence of ASCVD in patients with FH-phenotype (FH-P) and to compare it with that of normal low-density lipoprotein cholesterol (LDL-C) patients. We performed a retrospective cohort study using the Database of the Catalan primary care system, including ≥18-year-old patients with an LDL-C measurement. From 1,589,264 patients available before 2009, 12,823 fulfilled FH-P criteria and 514,176 patients were normolipidemic (LDL-C < 115 mg/dL). In primary prevention, patients with FH-P had incidences of ASCVD and coronary heart disease (CHD) of 14.9/1000 and 5.8/1000 person-years, respectively, compared to 7.1/1000 and 2.1/1000 person-years in the normolipidemic group. FH-P showed hazard ratio (HR) of 7.1 and 16.7 for ASCVD and CHD, respectively, in patients younger than 35 years. In secondary prevention, patients with FH-P had incidences of ASCVD and CHD of 89.7/1000 and 34.5/1000 person-years, respectively, compared to 90.9/1000 and 28.2/1000 person-years in the normolipidemic group (HR in patients younger than 35 years: 2.4 and 6.0). In the statin era, FH-P remains associated with high cardiovascular risk, compared with the normolipidemic population. This excess of risk is markedly high in young individuals.


2013 ◽  
Vol 167 (4) ◽  
pp. 1226-1231 ◽  
Author(s):  
L.G. Kearney ◽  
M. Ord ◽  
B.F. Buxton ◽  
G. Matalanis ◽  
S.K. Patel ◽  
...  

1986 ◽  
Vol 58 (3) ◽  
pp. 338-341 ◽  
Author(s):  
Kai-Sheng Hsieh ◽  
John F. Keane ◽  
Alexander S. Nadas ◽  
William F. Bernhard ◽  
Aldo R. Castaneda

1976 ◽  
Vol 144 (2) ◽  
pp. 444-455 ◽  
Author(s):  
Y K Ho ◽  
M S Brown ◽  
H J Kayden ◽  
J L Goldstein

Long-term established human lymphoid cells were shown to possess high affinity cell surface receptors for low density lipoprotein (LDL), the major cholesterol-carrying protein in human plasma. Binding of LDL to these receptors was followed by internalization of the lipoprotein and hydrolysis of its protein and cholesteryl ester components. Cultured lymphocytes from a patient with the homozygous form of familial hypercholesterolemia lacked cell surface LDL receptors and therefore failed to take up and degrade the lipoprotein with high affinity. Cultured human lymphocytes should prove useful for further studies of: (a) the relation between cholesterol metabolism and cellular function and (b) the mechanism by which LDL binding at the cell surface leads to internalization of the lipoprotein.


Sign in / Sign up

Export Citation Format

Share Document